AR031931A1 - Metodo de combinacion para el tratamiento de infecciones virales - Google Patents

Metodo de combinacion para el tratamiento de infecciones virales

Info

Publication number
AR031931A1
AR031931A1 ARP010105840A ARP010105840A AR031931A1 AR 031931 A1 AR031931 A1 AR 031931A1 AR P010105840 A ARP010105840 A AR P010105840A AR P010105840 A ARP010105840 A AR P010105840A AR 031931 A1 AR031931 A1 AR 031931A1
Authority
AR
Argentina
Prior art keywords
treatment
viral infections
combination method
polypeptide
pharmaceutically acceptable
Prior art date
Application number
ARP010105840A
Other languages
English (en)
Spanish (es)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AR031931A1 publication Critical patent/AR031931A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Peptides Or Proteins (AREA)
ARP010105840A 2000-12-19 2001-12-17 Metodo de combinacion para el tratamiento de infecciones virales AR031931A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25665700P 2000-12-19 2000-12-19

Publications (1)

Publication Number Publication Date
AR031931A1 true AR031931A1 (es) 2003-10-08

Family

ID=22973061

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010105840A AR031931A1 (es) 2000-12-19 2001-12-17 Metodo de combinacion para el tratamiento de infecciones virales

Country Status (12)

Country Link
US (1) US20050065319A1 (https=)
EP (1) EP1385534A2 (https=)
JP (1) JP2005500981A (https=)
CN (1) CN1481251A (https=)
AR (1) AR031931A1 (https=)
BR (1) BR0116253A (https=)
CA (1) CA2431919A1 (https=)
HU (1) HUP0302241A3 (https=)
MX (1) MXPA03005526A (https=)
NO (1) NO20032769L (https=)
WO (1) WO2002056902A2 (https=)
ZA (1) ZA200304560B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2400553A (en) * 2003-04-14 2004-10-20 Cipla Ltd Antiviral pharmaceutical combination of lamivudine, stavudine and efavirenz, or derivatives thereof
RU2353357C2 (ru) * 2003-05-16 2009-04-27 Юниверсити Оф Мэрилэнд Байотекнолоджи Инститьют Композиции для супрессии экспрессии ccr5 и способы их применения
EP1824886B1 (en) 2004-11-17 2010-12-22 Amgen Inc. Fully human monoclonal antibodies to il-13
JP2009517474A (ja) * 2005-11-30 2009-04-30 シェーリング コーポレイション Ｃｃｒ５拮抗剤およびｃｘｃｒ４拮抗剤の組み合わせを含む組成物
WO2007065007A2 (en) * 2005-12-01 2007-06-07 Government Of The U.S.A., As Repersented By The Secretary, Dept. Of Health And Human Services Treatment of viral infections
EP1886696A1 (en) * 2006-08-03 2008-02-13 Endotis Pharma Conjugates of antithrombin binding oligosaccharide derivatives and therapeutic proteins
CN104039815A (zh) * 2012-02-28 2014-09-10 中国人民解放军军事医学科学院毒物药物研究所 用于抑制hiv的多肽及其作用靶点
US11629196B2 (en) 2020-04-27 2023-04-18 Incelldx, Inc. Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464933A (en) * 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
AU723537B2 (en) * 1995-06-07 2000-08-31 Trimeris Inc. The treatment of HIV and other viral infections using combinatorial therapy
US6281331B1 (en) * 1998-03-23 2001-08-28 Trimeris, Inc. Methods and compositions for peptide synthesis
KR100439357B1 (ko) * 1999-05-04 2004-07-07 쉐링 코포레이션 Ｃｃｒ５ 길항제로서 유용한 피페리딘 유도체
US6391865B1 (en) * 1999-05-04 2002-05-21 Schering Corporation Piperazine derivatives useful as CCR5 antagonists
US6387930B1 (en) * 1999-05-04 2002-05-14 Schering Corporation Piperidine derivatives useful as CCR5 antagonists
US6689765B2 (en) * 1999-05-04 2004-02-10 Schering Corporation Piperazine derivatives useful as CCR5 antagonists
BR0010593A (pt) * 1999-05-04 2002-02-13 Schering Corp Terapia de combinação com antagonista de ccr5-interferon alfa peguilado para hiv

Also Published As

Publication number Publication date
WO2002056902A2 (en) 2002-07-25
HUP0302241A2 (hu) 2003-11-28
MXPA03005526A (es) 2003-10-06
CA2431919A1 (en) 2002-07-25
WO2002056902A3 (en) 2002-12-05
NO20032769L (no) 2003-08-18
US20050065319A1 (en) 2005-03-24
CN1481251A (zh) 2004-03-10
HUP0302241A3 (en) 2005-06-28
JP2005500981A (ja) 2005-01-13
BR0116253A (pt) 2006-05-02
NO20032769D0 (no) 2003-06-18
ZA200304560B (en) 2005-07-27
EP1385534A2 (en) 2004-02-04

Similar Documents

Publication Publication Date Title
LU92642I2 (fr) Pomalidomide et ses sels, solvates, hydrates ou stéréoisomères pharmaceutiquement acceptables qui endérivent (Imnovid)
ATE508735T1 (de) Pulmonale verabreichung von aminoglykosiden
MY141025A (en) Dose forms
AR062453A1 (es) Metodo de terapia combinada para el tratamiento de la infeccion por el virus de la hepatitis c y composiciones farmaceuticas para usar en dicha terapia
ECSP11011029A (es) Método para tratar o prevenir la trombosis usando etexilato de dabigatrán o una sal del mismo con una eficacia mejorada sobre la terapia con warfarina convencional.
GB0002336D0 (en) Medicaments
AR031931A1 (es) Metodo de combinacion para el tratamiento de infecciones virales
PA8467401A1 (es) Procedimiento para tratar la insuficiencia cardiaca
ATE273699T1 (de) Pharmazeutische verbindungen zur behandlung von chronisch-obstruktiver bronchopneumonie
ECSP22081150A (es) Composición farmacéutica para la prevención o tratamiento de enfermedad infecciosa viral de arn epidémica
AR119159A1 (es) Tratamientos de angioedema
ATE400564T1 (de) Ppar alpha selektive verbindungen zur behandlung von dyslipidämie und anderen lipidstörungen
NO20084053L (no) Inhibering av tumorvekst
CR8603A (es) Hidrocloruro de [4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il]-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos
ECSP014082A (es) Combinacion de secretagogos de hormona del crecimiento y antidepresivos
TW200501935A (en) Use of resveratrol for preparation of a medicament useful for the treatment of influenza virus infections
WO2003092608A3 (en) Methionine aminopeptidase-2 inhibitors and methods of use thereof
CO5200850A1 (es) Composicion farmaceutica para profilaxis y tratamiento de sintomas asociados con la gripa, influenza y enfermedades similares y procedimiento para su aplicacion
NO20013414L (no) Ny anvendelse av melagatran
EE200300129A (et) Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine
AR037967A1 (es) Utilizacion de desoxipeganina en el tratamiento de la depresion clinica
BG105984A (bg) Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението
AR030660A1 (es) Composicion farmaceutica para la prevencion o el tratamiento de una enfermedad asociada con un exceso de la produccion de il-12
AR032479A1 (es) Nuevas composiciones farmaceuticas que contienen epinastina y pseudoefedrina
DE602004022578D1 (de) Antitumorale terpen-verbindungen

Legal Events

Date Code Title Description
FB Suspension of granting procedure